Search Within

Helen Hyeong-Eun Won

  1. "Cancer Biology and Genetics Program Faculty"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Cancer Biology and Genetics Program Faculty (6)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  3. Department of Medicine (6)
  4. Department of Pathology and Laboratory Medicine (6)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Michael Berger (6)
  2. Maurizio Scaltriti (5)
  3. Scott Lowe (4)
  4. David Solit (3)
  5. Haley Ellis (3)
  6. Jose Baselga (3)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2015 (1)
  5. 2014 (2)
Publications
  1. Cancer Research (2)
  2. Cancer Discovery (1)
  3. European Journal of Cancer (1)
  4. Nature (1)
  5. Nature Medicine (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A rectal cancer organoid platform to study individual responses to chemoradiation
    Journal Article

    Ganesh, K.; Wu, C.; O’Rourke, K. P.; Szeglin, B. C.; Zheng, Y.; Sauvé, C. E. G.; Adileh, M.; Wasserman, I.; Marco, M. R.; Kim, A. S.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
    Journal Article

    Juric, D.; Castel, P.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ellis, H.; Ebbesen, S. H.; Ainscough, B. J.; Ramu, A.; Iyer, G.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Loss of PTEN leads to acquired resistance to the PI3Ka inhibitor BYL719: A case of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Gopakumar, I.; Quadt, C.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save